Loading...
News2018-05-28T17:13:48+00:00

Biohope, finalist in IV edition of the “RTVE Emprende Awards”

RTVE (National Spanish Television Channel) organized the IV Edition of the 'RTVE Emprende Awards', whose objective is to inform about companies that have stood out for their excellence in the professional field, contributing inherent values to the entrepreneur such [...]

September 17th, 2018|Categories: Awards and Recognitions|Tags: , |

Gaceta Médica, leading newspaper in health information, interviews Dra. Isabel Portero, CEO & Founder of BIOHOPE

"Closer to the personalization of renal transplant treatment. First study to evaluate the functionality of the immunobiogram to predict the immunosuppressive response." > Read  More

July 26th, 2018|Categories: Clinical Development, Research|Tags: , |

Interview with Isabel Portero, Founder and Director of Biohope

Isabel talks about the way she has professionally evolved, the achievements she has made and the promising future of Biohope, a highly qualified innovative Clinical stage biotech Company, thanks to the enthusiasm, ability to work [...]

July 18th, 2018|Categories: Business|Tags: , , |

Different media publish the new of the success of the immunobiogram

Following the presentation of Biohope at the Congress of the International Society of Transplantation held in Madrid, the media have published different articles on the results of the clinical study that demonstrate the usefulness of [...]

July 15th, 2018|Categories: Clinical Development, Research|Tags: , , |

First Patient in: TRANSBIO CLINICAL STUDY starts the recruitment

The TRANSBIO clinical study has started with inclusion of the first patient in the Hospital Puerta de Hierro (Madrid, Spain) on the 12th of June 2018, with Dr. José María Portoles as Principal Investigator. The University Hospital Puerta [...]

June 26th, 2018|Categories: ON THE MOVE|Tags: , , |

Biohope in Boston

Biohope is holding these days meetings in Boston with investors and companies  for future collaborations in the development of the Inmunobiogram®, cutting-edge technology in the treatment of chronic inflammatory diseases that will allow the personalization of [...]

June 7th, 2018|Categories: Collaborating Entities|